Sabra Health Care REIT, Inc. (SBRA)

NASDAQ: SBRA · USD

$19.0

-0.42 (-2.2%)· Recorded snapshot

Market cap	4.9B
Revenue (ttm)	863.8M
Net income (ttm)	65.4M
EPS (ttm)	$0.26
Shares out	255.5M
P/E (trailing)	72.8x
P/E (forward)	26.7x
Dividend	$1.20 (6.30%)
Volume	1,695,839
Beta	0.62

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 863.8M
Net income (ttm): 65.4M
EPS (ttm): $0.26
P/E (trailing): 72.8x
P/E (forward): 26.7x
Market cap: 4.9B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
AMT	American Tower Corporation	85.1B	25.8x	7.5x	7.8%	+4.0%	+0.7%	비중 축소
ARE	Alexandria Real Estate Equities Inc.	6.9B	—	2.4x	0.9%	+6.6%	-45.8%	보유
CCI	Crown Castle Inc.	37.4B	46.3x	9.1x	5.1%	-7.9%	-6.2%	매도

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E26.7

P25 11.8P50 26.8P75 44.2

Trailing P/E72.8

P25 14P50 22.5P75 42.8

ROE2.4

P25 -2P50 3.9P75 8.9

ROIC2.9

P25 0.5P50 2.5P75 4.8

Benchmarks · 1M

All SBRA indicators

Market & fundamental data

Available fields

247

Groups with data

Currency

USD

Showing 247 of 247 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001492298
Company name	Sabra Health Care REIT, Inc.
Country	United States
Country code	US
CUSIP number	78573L106
Earnings date	2026-11-02
Earnings time	amc
Employees	58
Employees change	8
Employees growth	16%
Enterprise value	$7.2B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2010
In index	RUSSELL2000
Industry	REIT - Healthcare Facilities
Is primary listing	Yes
Is SPAC	No
ISIN number	US78573L1061
Last 10-K release date	2026-02-12
Last earnings date	2026-08-03
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$4.9B
Market cap category	Mid-Cap
Next earnings date	2026-11-02
Options	Yes
Price	$19.03
Price currency	USD
Sector	Real Estate
SIC code	6798
Stock price date	2026-10-28
Symbol	SBRA
U.S. state	California
Website	https://www.sabrahealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	29.93x
Average P/E ratio (10Y)	57.14x
Average P/E ratio (3Y)	60.91x
Earnings yield	1.37%
EV/Earnings	110.49x
EV/EBIT	43.92x
EV/EBITDA	19.59x
EV/Sales	8.37x
FCF / EV yield	-5.06%
FCF yield	-7.55%
Forward EV/Sales	7.34x
Forward P/E	26.72x
Forward P/S	4.92x
Graham number	7.95996
Graham upside	-58.02%
Industry forward P/E	71.56x
Industry P/E	86.08x
P/(OCF - SBC) ratio	13.51x
P/B ratio	1.81x
P/E ratio	72.76x
P/FFO ratio	18.36x
P/OCF ratio	13.04x
P/S ratio	5.61x
PEG ratio	3.77x
Price / tangible book value	1.82x
Price/EBITDA ratio	13.12x
Sector forward P/E	30.05x
Sector P/E	41.38x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	19.06%
EBITDA margin	42.74%
Effective tax rate	3.16%
Gross margin	50.27%
Operating margin	19.06%
Pretax margin	7.8%
Profit margin	7.58%
Profit per employee	$1.1M
Profitable years	3
Revenue per employee	$14.9M
ROA	1.9%
ROA (5Y)	2.07%
ROCE	3.05%
ROE	2.39%
ROE (5Y)	0.98%
ROIC	2.94%
ROIC (5Y)	3.28%
SBC / revenue	1.52%
Tax / revenue	0.25%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-65.57%
EPS growth 10Y	-10.98%
EPS growth years	4
Net income growth	-64.11%
Net income growth years	4
OCF growth	9.66%
OCF growth (Q)	6%
OCF growth (QoQ)	-12.75%
OCF growth 10Y	8.5%
OCF growth 3Y	5.7%
OCF growth 5Y	1.88%
Revenue growth	17.68%
Revenue growth (Q)	25.32%
Revenue growth (QoQ)	6.45%
Revenue growth 10Y	12.61%
Revenue growth 3Y	16.84%
Revenue growth 5Y	14.24%
Revenue growth quarters	10
Revenue growth years	4

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-737.4M
Depreciation and amortization	$209.4M
EBIT	$164.6M
EBITDA	$369.2M
EPS	$0.26
FCF per share	$-1.43
Financing cash flow	$100M
Free cash flow	$-365.9M
Free cash flow minus SBC	$-379M
Funds from operations (FFO)	$260.3M
Gross profit	$434.2M
Income taxes	$2.1M
Investing cash flow	$-335M
Net cash flow	$136.7M
Net income	$65.4M
Operating cash flow minus SBC	$358.4M
Operating income	$164.6M
Revenue	$863.8M
Stock-based compensation	$13.1M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	$10.77
Debt / EBITDA	7.11
Debt / equity	0.96
Interest coverage	1.42
Net cash (debt)	$-2.4B
Net cash / market cap	-49.28%
Net debt / EBITDA	6.47
Net debt / equity	0.87
Piotroski F-Score	6
Property, plant and equipment	$4.8B
Shareholders' equity	$2.8B
Tangible book value	$2.7B
Tangible book value per share	$10.44
Total assets	$5.5B
Total cash	$246.3M
Total debt	$2.6B
Total liabilities	$2.8B
WACC	6.45%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.16
Current ratio	3.57
Net working capital	$36.9M
Quick ratio	3.25
Working capital	$281.6M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-5.18%
Dividend growth	0%
Dividend growth (10Y)	-3.19%
Dividend growth (3Y)	0%
Dividend growth (5Y)	0%
Dividend growth years	0
Dividend payment date	2026-08-31
Dividend payment years	16
Dividend payout frequency	Quarterly
Dividend per share	$1.20
Dividend yield	6.3%
Ex-dividend date	2026-08-14
Last dividend	$0.30
Payout ratio	458.84%
Shareholder yield	1.15%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-17.96%
10Y return CAGR	6.32%
10Y total return	84.46%
150-day SMA	$20.03
15Y price change	83.37%
15Y return CAGR	12.4%
15Y total return	477.64%
1D price change	-2.16%
1M price change	-4.48%
1M total return	-4.48%
1W price change	-2.37%
1W total return	-2.37%
1Y price change	3.38%
1Y return CAGR	9.82%
1Y total return	9.82%
20-day SMA	$19.21
200-day SMA	$19.97
3M price change	-15.32%
3M total return	-14.04%
3Y price change	41.39%
3Y return CAGR	20.41%
3Y total return	74.61%
50-day SMA	$19.90
50-day SMA vs 200-day SMA	50under200
52-week high	$22.77
52-week high date	2026-07-28
52-week low	$17.17
52-week low date	2025-10-29
5Y price change	27.16%
5Y return CAGR	13.55%
5Y total return	88.78%
6M price change	-6.53%
6M total return	-3.76%
All-time high	$34.44
All-time high date	2015-03-24
All-time low	$5.55
All-time low date	2020-03-18
Average true range (ATR)	$0.43
Average volume	2.3M
Beta (1Y)	-0.01
Beta (2Y)	0.11
Beta (5Y)	0.62
Change from 52-week high	-16.43%
Change from 52-week low	10.87%
Change from all-time high	-44.94%
Change from all-time low	241.93%
Change from open	-1.25%
Day's gap	-0.93%
Dollar volume	$32.3M
High price	$19.27
Low price	$18.90
Monthly RSI	51.81
Open price	$19.27
Position in 52-week range	35.14%
Premarket change	-0.51%
Premarket close	$19.45
Premarket price	$19.35
Premarket volume	985
Previous close	$19.45
Price vs 150-day SMA	-5.36%
Price vs 20-day SMA	-1.29%
Price vs 200-day SMA	-5.03%
Price vs 50-day SMA	-4.74%
Relative volume	0.72
RSI	41.9
Sharpe ratio	0.34
Sharpe ratio (3Y)	0.68
Sharpe ratio (5Y)	0.43
Sortino ratio	0.78
Sortino ratio (3Y)	1.26
Sortino ratio (5Y)	0.84
Volume	1.7M
Weekly RSI	42.63
YTD price change	0.11%
YTD total return	4.63%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	251.3M
Float percentage	98.38%
Shares change (QoQ)	-1.44%
Shares change (YoY)	5.18%
Shares held by insiders	1.58%
Shares held by institutions	103.74%
Shares outstanding	255.5M
Short % of float	7.05%
Short % of shares	6.94%
Short ratio	8.2 days

Deeper analysis on SBRA

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this SBRA report

Is a complete SBRA research report available?

No complete published report is available for Sabra Health Care REIT, Inc. (SBRA) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Sabra Health Care REIT, Inc. (SBRA)

Price

Financial snapshot

Fair-value bridge

Latest news · SBRA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SBRA indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SBRA

Frequently asked questions